Cargando…
COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation
We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexamethasone and tocilizumab. One week after discharge, he developed abnormal be...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267028/ https://www.ncbi.nlm.nih.gov/pubmed/34229469 http://dx.doi.org/10.1177/23247096211029787 |
_version_ | 1783720053696364544 |
---|---|
author | Hara, Makoto Kouda, Kento Mizoguchi, Tomotaka Yokota, Yuki Hayashi, Kentaro Gon, Yasuhiro Nakajima, Hideto |
author_facet | Hara, Makoto Kouda, Kento Mizoguchi, Tomotaka Yokota, Yuki Hayashi, Kentaro Gon, Yasuhiro Nakajima, Hideto |
author_sort | Hara, Makoto |
collection | PubMed |
description | We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexamethasone and tocilizumab. One week after discharge, he developed abnormal behavior and delirium without fever and respiratory symptoms. Brain magnetic resonance imaging showed no abnormalities. Cerebrospinal fluid showed pleocytosis and elevated protein concentrations and was negative for severe acute respiratory syndrome-coronavirus-2 RNA. No anti-neuronal autoantibodies against intracellular and neuronal surface proteins were detected. The cerebrospinal fluid inflammatory changes compatible with post-infectious encephalitis, and the patient recovered with intravenous methylprednisolone and intravenous immunoglobulin therapy. Delirium could be an initial symptom of post-infectious encephalitis in older adults with COVID-19, and these patients may require immunosuppressive therapy. |
format | Online Article Text |
id | pubmed-8267028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-82670282021-07-19 COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation Hara, Makoto Kouda, Kento Mizoguchi, Tomotaka Yokota, Yuki Hayashi, Kentaro Gon, Yasuhiro Nakajima, Hideto J Investig Med High Impact Case Rep Case Report We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexamethasone and tocilizumab. One week after discharge, he developed abnormal behavior and delirium without fever and respiratory symptoms. Brain magnetic resonance imaging showed no abnormalities. Cerebrospinal fluid showed pleocytosis and elevated protein concentrations and was negative for severe acute respiratory syndrome-coronavirus-2 RNA. No anti-neuronal autoantibodies against intracellular and neuronal surface proteins were detected. The cerebrospinal fluid inflammatory changes compatible with post-infectious encephalitis, and the patient recovered with intravenous methylprednisolone and intravenous immunoglobulin therapy. Delirium could be an initial symptom of post-infectious encephalitis in older adults with COVID-19, and these patients may require immunosuppressive therapy. SAGE Publications 2021-07-07 /pmc/articles/PMC8267028/ /pubmed/34229469 http://dx.doi.org/10.1177/23247096211029787 Text en © 2021 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Hara, Makoto Kouda, Kento Mizoguchi, Tomotaka Yokota, Yuki Hayashi, Kentaro Gon, Yasuhiro Nakajima, Hideto COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation |
title | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation |
title_full | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation |
title_fullStr | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation |
title_full_unstemmed | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation |
title_short | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation |
title_sort | covid-19 post-infectious encephalitis presenting with delirium as an initial manifestation |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267028/ https://www.ncbi.nlm.nih.gov/pubmed/34229469 http://dx.doi.org/10.1177/23247096211029787 |
work_keys_str_mv | AT haramakoto covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation AT koudakento covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation AT mizoguchitomotaka covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation AT yokotayuki covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation AT hayashikentaro covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation AT gonyasuhiro covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation AT nakajimahideto covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation |